Approval · Notice of Compliance 5157 · 1995
KENRAL-MPA: Notice of Compliance 5157
Issued January 24, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5157
- Date
- January 24, 1995
- Company
- Kenral Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change, revised product monograph
- Therapeutic class
- Progestin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KENRAL-MPA | 02148552 | Cancelled Post Market |
| KENRAL-MPA | 02148560 | Cancelled Post Market |
| KENRAL-MPA | 02148579 | Cancelled Post Market |
Medicinal ingredients
- MEDROXYPROGESTERONE ACETATE 2.5 MG per TAB
- MEDROXYPROGESTERONE ACETATE 5 MG per TAB
- MEDROXYPROGESTERONE ACETATE 10 MG per TAB